Work

The future of tyrosine kinase inhibitors: Single agent or combination?

Year: 2008

Type: article

Source: Current Oncology Reports

DOI: 10.1007/s11912-008-0040-9

Author: Keith T. Flaherty

Institutions: Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1965113601

FWCI: 1.391

Cites: 33

Cited by: 10

Related to: 10